Adrian Miranda - 24 Aug 2026 Form 4 Insider Report for Neuraxis, INC (NRXS)

Reporting relationship: CMO, SVP Science & Tech
Issuer ticker: NRXS
Reported as of: 24 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Aug 2026, 17:30:00 UTC
Prior SEC filing: 17 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Adrian Miranda

Key filing fact

Adrian Miranda filed Form 4 for Neuraxis, INC (NRXS) on 26 Aug 2026.

Key facts

This page summarizes Adrian Miranda's Form 4 filing for Neuraxis, INC (NRXS).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 26 Aug 2026, 17:30.

Change

Previous filing in this sequence was filed on 17 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001992525 Primary reporting owner

Miranda Adrian

Relationship: CMO, SVP Science & Tech
Address: 11611 N. MERIDIAN ST,, SUITE 330, CARMEL
Signature: /s/ Adrian Miranda
Signature date: 26 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXS transaction

Common Stock

Award

Transaction value
Shares: +199,106
Change %
Price
Shares after: 199,106
Date: 24 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NRXS transaction Derivative

Stock Options

Conversion of derivative security

Transaction value
Shares: -337,204
Change %: -100%
Price: $6.94^*
Shares after: 0
Date: 24 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 337,204
Exercise price
Footnotes: F2

NRXS transaction Derivative

RSU

Award

Transaction value
Shares: +337,204
Change %
Price
Shares after: 337,204
Date: 24 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 337,204
Exercise price
Footnotes: F2

NRXS transaction Derivative

RSU

Conversion of derivative security

Transaction value
Shares: -337,204
Change %: -100%
Price
Shares after: 0
Date: 24 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 337,204
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reference is made to the 337,204 restricted stock units ("RSUs") granted and vested to the Reporting Person under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan as discussed below, of which 138,098 shares were withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of RSUs.

Footnote F2

Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant.